NCT00314340View on ClinicalTrials.gov

A Comparison of the Addiction Liability of Hydrocodone and Sustained Release Morphine

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Chronic Pain
Interventions
BEHAVIORAL

Markers of Abuse Liability, Neuropsych Testing, and Cue Reactivity

The first dose of the study medication was taken following collection of baseline measurements, and subsequent measurements were taken hourly thereafter. Respiration, heart rate, arterial oxygen saturation (pulse oximetry), and blood pressure were also monitored at these intervals to insure the safety of subjects.

DRUG

ER Morphine

DRUG

hydrocodone plus acetaminophen

DRUG

placebo

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT00314340 - A Comparison of the Addiction Liability of Hydrocodone and Sustained Release Morphine | Biotech Hunter | Biotech Hunter